|
ENTPD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.607100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.780800E-03 |
| Normal-vs-Stage2 |
9.444800E-01 |
| Normal-vs-Stage3 |
4.39480000000714E-05 |
| Normal-vs-Stage4 |
6.09489999999768E-05 |
| Stage1-vs-Stage2 |
1.650220E-01 |
| Stage1-vs-Stage3 |
8.482000E-02 |
| Stage1-vs-Stage4 |
6.985500E-02 |
| Stage2-vs-Stage3 |
4.256000E-02 |
| Stage2-vs-Stage4 |
3.488400E-02 |
| Stage3-vs-Stage4 |
8.041000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.835460E-03 |
| Normal-vs-AfricanAmerican |
3.249600E-02 |
| Normal-vs-Asian |
3.338800E-03 |
| Caucasian-vs-AfricanAmerican |
9.940400E-01 |
| Caucasian-vs-Asian |
5.155200E-01 |
| AfricanAmerican-vs-Asian |
6.522000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.002400E-02 |
| Normal-vs-Female |
1.057640E-03 |
| Male-vs-Female |
9.402000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.775700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.15859999999468E-05 |
| Normal-vs-Age(61-80Yrs) |
3.326200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.477700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.539700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.587800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.991600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.605200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.236200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.454400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.418400E-03 |
| Classical-VS-Follicular |
5.526800E-01 |
| Classical-VS-Other |
6.171800E-01 |
| Classical-VS-Normal |
4.136600E-03 |
| Tall-VS-Follicular |
8.739400E-03 |
| Tall-VS-Other |
5.583000E-01 |
| Tall-VS-Normal |
2.28169999999528E-05 |
| Follicular-VS-Other |
5.214600E-01 |
| Follicular-VS-Normal |
7.946100E-02 |
| Other-VS-Normal |
7.339900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.137900E-03 |
| Normal-vs-N1 |
3.92209999999782E-05 |
| N0-vs-N1 |
5.452400E-02 |
|
|
